Real-world clinical experience with the novel IBS-specific guided diagnostic therapy to be presented at the world’s largest GI medical conference, May 2–5, 2026, in ChicagoIRVINE, Calif., April 29, ...

Too often, people promote remedies for irritable bowel syndrome that have little to no scientific backing.

The biotech’s CEO, Dr James McIlroy, says EBX-102-02 could address significant treatment gaps in IBS, which impacts up to 10% ...

Jeffrey Lackner, PsyD, a pioneer in research on CBT for IBS, discusses barriers in access to treatment and the need for increased awareness. Irritable bowel syndrome (IBS) is characterized by ...

April is IBS Awareness Month. Learn about irritable bowel syndrome symptoms, diagnosis, and treatment options.

From abdominal pain and bloating to urgent bathroom trips and constipation, irritable bowel syndrome (IBS) can be a disruptive condition to live with. Fortunately, there are treatments available that ...

NEW IBS research highlights persistent pain treatment gaps and points to peripheral nerve targets for future, safer therapies ...

With this protocol, "for the most part, symptom improvement is sustained out to 3 months and 6 months," said investigator Jeffrey Lackner, PsyD, from the University of Buffalo School of Medicine in ...

Drs Lin Chang and Douglas Drossman discuss the history of IBS, the gut-brain axis, the role of trauma and stress in IBS, and share pearls for implementing biopsychosocial care in the clinic. Join Drs ...

Digestive discomfort affects nearly everyone at some point, but persistent symptoms can signal two very different conditions that millions of people struggle to distinguish. Irritable bowel syndrome ...

Kevin Yu thinks back on the terrible year his stomach held him "prisoner." There was constant pain, the incessant urge to use the bathroom from the moment he woke up until he went to bed. "The only ...

IBS is a chronic gut disorder with discomfort and bowel changes, but no visible damage. IBS is categorized by bowel habits: constipation (IBS-C), diarrhea (IBS-D), mixed (IBS-M), and post-infectious.